Us Bancorp \De\ Omeros Corp Transaction History

Us Bancorp \De\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$1.92 - $6.28 $403 - $1,318	-210 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$5.07 - $7.2 $851 - $1,209	168 Added 400.0%	210 $1,000
Q4 2021 Feb 11, 2022	SELL	$5.67 - $8.54 $2,233 - $3,364	-394 Reduced 90.37%	42 $0
Q4 2020 Feb 04, 2021	BUY	$10.14 - $15.19 $4,421 - $6,622	436 New	436 $6,000
Q3 2020 Nov 10, 2020	SELL	$9.57 - $21.32 $756 - $1,684	-79 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$12.21 - $16.99 $2,771 - $3,856	-227 Reduced 74.18%	79 $1,000
Q1 2020 May 13, 2020	BUY	$9.03 - $19.72 $2,763 - $6,034	306 New	306 $4,000

123

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $576M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.